6533b837fe1ef96bd12a22d2

RESEARCH PRODUCT

Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

Maria Cristina MaggioLuca CantariniGiovanni CorselloUmberto CorporaRolando Cimaz

subject

Settore MED/38 - Pediatria Generale E SpecialisticaAutoinflammatory syndromes anti-IL-1 IL-1

description

Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.

http://hdl.handle.net/10447/390109